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Abstract 
Background: In cross-sectional studies, cocaine users generally display elevated levels of self-
reported and cognitive impulsivity. To what extent these impairments are stable vs. variable markers 
of cocaine use disorder, and, thus, are pre-existing or drug-induced, has not been systematically 
investigated yet.  
 
Methods: We conducted a longitudinal study with cocaine users who changed or maintained their 
consumption intensity, measuring self-reported impulsivity with the Barratt Impulsiveness Scale (BIS-
11), and cognitive impulsivity with the Rapid Visual Processing Task (RVP), Iowa Gambling Task 
(IGT), and Delay Discounting Task (DD) at baseline and at one-year follow-up. We assessed 48 
psychostimulant-naïve controls and 19 cocaine users with decreased, 19 users with increased, and 19 
users with unchanged cocaine intake after one year as confirmed by hair analysis.  
 
Results: Results of linear multilevel modelling showed significant group*time interactions for the 
BIS-11 total score and the IGT total card ratio. Increasers showed a trend for elevated, whereas 
decreasers exhibited reduced self-reported impulsivity scores within one year. Surprisingly, 
increasers’ IGT performance was improved after one year, whereas decreasers’ performance 
deteriorated. By contrast, neither RVP response bias B’’ nor DD total score showed substantial 
group*time interactions. Importantly, BIS-11 and DD revealed strong test-retest reliabilities.  
 
Conclusion: Self-reported impulsivity (BIS-11) and decision-making impulsivity (IGT) co-vary with 
changing cocaine use, whereas response bias and delay discounting remain largely unaffected. Thus, 
self-reported impulsivity and gambling decision-making were strongly state-dependent in a stimulant-
using population and may be suitable to monitor treatment success, whereas delay of gratification was 
confirmed as a potential endophenotype of stimulant addiction. 
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Introduction 
Cocaine addiction is a debilitating chronically relapsing disorder that is characterised by 
persistent and compulsive drug-seeking despite harmful consequences (APA 1994). Cocaine is the 
most commonly used stimulant drug in Europe and the United States (EMCDDA 2014; UNODC 
2014) and current lifetime prevalence rates in the populations are estimated at 4.2% in Europe and 
14.3% in the United States (EMCDDA 2014; NSDUH 2014). Despite the high addiction liability of 
cocaine (Nutt et al. 2007), only a relatively small fraction of users (5 to 6%) made the transition from 
controlled drug use to drug dependence within the first year of use, whereas 15 to 16% developed 
dependency in the long run (Wagner & Anthony 2002).  
Converging evidence points to a complex interplay of inherited genetic predispositions and 
environmental, social, and neurobiological factors contributing to the vulnerability to develop an 
addiction (Kendler et al. 2007; Kreek et al. 2005). It has been postulated that chronic drug use is 
associated with neuroadaptations in fronto-limbic brain circuits mediating reward, motivation, and 
memory processes, presumably resulting in behavioural inflexibility such as disrupted self-control and 
compulsive drug use (Goldstein & Volkow 2011). However, the emerging concept of addiction 
endophenotypes also highlights the role of pre-existing psychological, cognitive, and neurobiological 
factors that may render an individual more susceptible to initiate drug use and develop an addiction 
(2013; Ersche et al. 2012; Mahoney & Olmstead 2013). Important and somewhat conceptually 
overlapping key factors implicated in the initiation and maintenance of drug use are maladaptive 
decision-making, increased impulsivity propensities, and implicit cognitive processes such as 
attentional bias and implicit memory associations (Field et al. 2008; Lucantonio et al. 2012; Marhe et 
al. 2013; Stevens et al. 2014; Wiers & Stacy 2006). Overall, drug users attribute excessive attention to 
drug-related stimuli, rate them more positively than non-users, and exhibit reduced inhibitory control 
and increased impulsivity, leading to harmful compulsive drug use despite the occurrence of negative 
consequences. 
To what extent impaired decision-making and increased impulsivity are drug-induced, pre-
existing vulnerability factors, or a combination of both is, however, not entirely clear so far. 
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Decision-making refers to the ability to select an optimal course of action from multiple options, 
requiring ongoing updating and integrating of the value of present and potential actions (Fellows 2004; 
Lucantonio et al. 2012). Prior studies have consistently shown that dependent cocaine users exhibit 
disadvantageous decision-making strategies in tasks such as the Iowa Gambling Task (IGT) and 
preferences for smaller immediate over larger but delayed rewards as measured with the Delay 
Discounting Task (DD)(Bechara et al. 2002; Hulka et al. 2014; Kjome et al. 2010; Verdejo-Garcia et 
al. 2007). Impulsivity, a multi-facetted concept, is generally defined as a predisposed tendency toward 
rapid and unplanned reaction patterns without much foresight regarding possible consequences 
(Moeller et al. 2001a). Impulsive tendencies or trait impulsivity is generally assessed with self-report 
questionnaires, such as the Barratt Impulsiveness Scale (BIS), which presumably focus on stable 
personality characteristics (Patton et al. 1995; Stevens et al. 2014). Although self-report measures can 
provide valuable information, they can be limited if the subject lacks insight or answers in a socially 
desirable manner (Moeller et al. 2001a). Therefore, using an experimental approach to complement 
self-report measures of impulsivity with behavioural performance measures is essential. Behavioural 
or neurocognitive impulsivity has been proposed to include the two main components of impulsive 
action representing motor impulsivity and impulsive choice reflecting more cognitive parts of 
impulsivity (Winstanley et al. 2010). Impulsive action is generally measured with tasks assessing the 
ability to inhibit motor responses (e.g., Stop-Signal, Stroop, Go/No-go, and sustained attention tasks 
such as the Rapid Visual Processing [RVP]), while impulsive choice is either assessed with tasks 
quantifying the ability to tolerate delay of gratification such as the DD or with tasks measuring 
responses to reward and loss contingencies such as assessed in the IGT (Stevens et al. 2014; 
Winstanley et al. 2010). It has been suggested that impulsive action might be more associated with the 
development of cocaine addiction, while impulsive choice may contribute specifically to relapse of 
cocaine use (Winstanley et al. 2010). However, this hypothesis has been recently challenged as we did 
not find elevated motor impulsivity in cocaine dependence (Vonmoos et al. 2013b), while especially 
DD – a prototype of impulsive choice – has been proposed as a critical risk factor for the development 
of drug addiction as well (MacKillop 2013). 
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Elevated trait impulsivity has consistently been reported for dependent and recreational 
stimulant users (Reske et al. 2011; Vonmoos et al. 2013b), whereas results on behavioural impulsivity 
are somewhat mixed: some studies found dependent (Ersche et al. 2010; Perry & Carroll 2008; 
Verdejo-Garcia et al. 2008) and recreational cocaine users (CU)(Colzato et al. 2007) to be impaired in 
Stop-Signal or Go/No-go tasks, whereas we recently concluded from data of a large sample of 
relatively pure CU that neither dependent nor recreational cocaine use was associated with impairment 
in the Stop-Signal task (Vonmoos et al. 2013b). However, the inconsistent results regarding 
performance in Stop-Signal tasks may be explained by different task designs and parameter calculation 
procedures as well as different exclusion criteria of polytoxic drug use and psychiatric comorbidities 
(Vonmoos et al. 2013b).  
Importantly, impaired decision-making and social cognition in CU have been associated with 
worse self-reported real-life functioning (Cunha et al. 2011; Preller et al. 2014) and more frequent 
drug relapse and treatment attrition (Aharonovich et al. 2006; Bechara 2003; Verdejo-Garcia et al. 
2014). Moreover, elevated levels of impulsivity have been associated with an increased risk to initiate 
and continue drug use and a greater likelihood of relapse (for review see Stevens et al. 2014). 
Considering the impact of impaired decision-making and elevated impulsivity on real-life functioning 
and treatment outcome, it is important to better understand if the different facets of impulsivity are 
stable antecedent vulnerability factors – predisposing individuals to develop and maintain cocaine 
addiction – or rather drug-induced consequences. Moreover, it is not clear whether these behavioural 
deviances are reversible when drug use is reduced or completely ceased. Recently, we reported that 
CU, who had substantially increased cocaine use over the course of one year, exhibited worse 
cognitive performance compared to baseline, whereas those who decreased or ceased their cocaine use 
showed substantially improved cognitive performance, suggesting that cognitive impairment is 
partially cocaine-induced but also reversible (Vonmoos et al. 2014). 
The primary goal of the present investigation was thus to determine which specific decision-
making and impulsivity components are stable (addiction endophenotypes) vs. variable (drug-induced) 
markers of cocaine use disorder over the time-course of one year. For this purpose, we conducted a 
longitudinal study assessing trait impulsivity with the BIS-11, impulsive action with the RVP response 
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bias B’’, and impulsive choice with the main IGT and DD parameters, at baseline and after one year. 
CU of the Zurich Cocaine Cognition Study (ZuCo2St) were categorized as decreasers, increasers, or 
equal users after the one-year follow-up based on a toxicological quantification of cocaine levels in 
hair samples. With regard to the BIS-11 and DD, we expected that scores would remain stable over the 
two assessments because the BIS-11 is regarded as a trait measure and also discounting preferences 
appear to be relatively stable over time (for review see MacKillop 2013). For the RVP B’’ we 
expected stable results as none of the few existing previous studies with CU displayed a substantial 
cocaine-associated effect on this parameter (Ersche et al. 2011; Vonmoos et al. 2013b). By contrast, 
we expected that the IGT performance would improve with decreased cocaine use and worsen with 
increased cocaine use as prior studies reported dose-dependent relationships between cocaine use and 
IGT performance (Verdejo-Garcia et al. 2007).  
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Materials and Methods 
Participants  
The eligible baseline sample of the ZuCo2St comprised 234 participants (138 CU, 96 healthy 
psychostimulant-naive controls [HC])(Hulka et al. 2014; Preller et al. 2014; Vonmoos et al. 2013a). 
One-hundred-and-thirty-two subjects (79 CU [57.3% of baseline], 53 HC [55.2%]) participated in the 
1-year-follow-up. Hereof, 57 CU and 48 matched HC could be included in the longitudinal analysis 
(for details see online Supplementary Methods S1). 
At baseline, exclusion criteria for all participants were clinically significant somatic diseases, 
neurological disorders, head injuries, family history of schizophrenia, obsessive-compulsive disorder, 
or bipolar disorder, or any medication affecting the CNS. Further exclusion criteria for CU were 
opioid use, polytoxic drug use patterns, or DSM-IV axis I psychiatric disorders (except for cocaine, 
nicotine, and alcohol abuse/dependence, former affective disorders, and attention deficit hyperactivity 
disorder). At baseline, all CU met the following inclusion criteria: cocaine as primary drug of choice, 
cocaine use >0.5 g/month, and abstinence duration of <6 months. Exclusion criteria for HC were 
DSM-IV axis I psychiatric disorders (excluding nicotine dependence) and regular illegal drug use (>15 
lifetime occasions, except occasional cannabis use). 
Participants were asked to abstain from illegal substances for >72h and from alcohol for >24h. 
Compliance was controlled by urine screens (semi-quantitative enzyme multiplied immunoassay 
method) and 6-month hair toxicology (Vonmoos et al. 2013a). The study was approved by the 
Cantonal Ethics Committee of Zurich. All participants provided written informed-consent statements 
and were compensated for their participation.  
 
Cocaine user groups  
Cocaine user groups were determined based on a combination of absolute (±0.5 ng/mg 
cocaine)(Bush 2008; Cooper et al. 2012) and relative (>10% increase/decrease in the robust hair 
toxicology parameter cocainetotal)(Hoelzle et al. 2008) changes in cocaine concentration in the hair 
samples between baseline and follow-up. CU who met both criteria were categorized as increasers or 
decreasers accordingly, whereas CU who met none or only one criterion were classified as equal users. 
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Accordingly, CU were divided into three equally sized groups: Whereas 19 CU with increased 
cocaine use and 19 CU with decreased cocaine use met the according change criteria, a third group of 
19 CU displayed equal cocaine use and met neither the cut-off-criteria for increased nor decreased 
cocaine use (increaser mean±SD +30.4±61.9 ng/mg [+297%], range +0.5 to +268.5 ng/mg [+20% to 
+5374%]; decreaser -10.6±26.7 ng/mg [-72%], -116.9 to -0.6 ng/mg [-100% to -12%]; equal user -
0.1±0.5 ng/mg [-2%], -1.9 to +0.5 ng/mg [-100% to +720%]). 
 
Procedure 
The test procedure was similar in both test sessions. The Structured Clinical Interview for DSM-
IV axis I disorders (SCID-I; APA 1994) was carried out by trained psychologists. Drug use was 
assessed by means of a structured and standardized interview for psychotropic drug consumption 
(Quednow et al. 2004). For matching reasons, pre-morbid verbal intelligence was measured with a 
German version of a multiple choice vocabulary intelligence test (MWT-B; Lehrl 1999). Attention 
Deficit Hyperactivity Disorder (ADHD) symptoms were assessed with the ADHD Self-Rating Scale 
(ADHD-SR; Roesler et al. 2004), and symptoms of depression with the Beck Depression Inventory 
(BDI; Beck et al. 1961). Smoking severity was assessed with the Fagerström Test of Nicotine 
Dependence (FTND; Heatherton et al. 1991) and craving for cocaine with the Brief Cocaine Craving 
Questionnaire (CCQ; Sussner et al. 2006). Smoking intensity and cocaine craving were assessed to 
control for their potential acute effects on test performance (Franken 2003). Trait impulsivity was 
assessed with the BIS-11 (Patton et al. 1995). The two components of cognitive impulsivity impulsive 
action and impulsive choice were measured by means of the response bias B’’(an analogue to the 
response bias beta from the signal detection theory; Green & Swets 1966) drawn from the sustained 
attention task Rapid Visual Processing (RVP) of the Cambridge Automated Neuropsychological Test 
Battery (CANTAB; Elliott et al. 1996) as well as the discounting rate described by parameter k from 
the DD Task (Kirby et al. 1999), and the IGT parameter total ratio (number of good cards-number of 
bad cards)(Bechara et al. 2002), respectively. At follow-up, a parallel test-version was used for the 
IGT. Detailed task descriptions for the RVP, IGT, and DD can be found in the online Supplementary 
Methods S2. 
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Statistical analysis 
Statistical analyses regarding demographic data and drug use patterns (Table 1) as well as 
baseline test scores were performed with SPSS Statistics 19.0 (IBM, Switzerland). Frequency data 
were analyzed by means of Pearson’s chi-squared test and quantitative data by analyses of variance 
(ANOVA) or Student’s t-tests. All other analyses derived from the xtmixed command in Stata 12.1 for 
Macintosh (StataCorp. 2011). Regression modelling involved a series of linear multilevel models (also 
known as linear mixed, random-effects, or random-coefficient models)(Gelman & Hill 2007; Locascio 
& Atri 2011; Tabachnik & Fidell 2006).  
All dependent variables were divided by their respective standard deviations to aid in model 
interpretation. Predictors evaluated were: group (increasers, decreasers, equal users, controls), time 
(dummy variable with levels baseline and follow-up), group*time interaction, female sex, age (in 10-
year-steps), level of education (years), age of onset of cocaine use (in 5-year-steps), verbal IQ (in steps 
of 5), amount of Swiss Francs available in the last 12 months (ordinal variable with levels 0-15000, 
15000-30000, 30000-60000, 60000-90000, 90000-120000, >120000), FTND score (divided by 
standard deviation), smoker (yes/no), ADHD-SR score (divided by standard deviation), adult ADHD 
(yes/no, DSM-IV criteria), BDI score (divided by standard deviation), BDI depression (yes/no, cut-off 
≥18), CCQ score (divided by standard deviation), years of cocaine use, cumulative cocaine use in 
grams (transformed by natural logarithm because of violation of normality distribution), cocaine in 
hair samples (pg/mg), positive urine screen for cocaine (yes/no), and cocaine level in urine toxicology 
(ng/ml, log-transformed). Continuous predictors were centered on their grand means. In addition to 
some of the predictors (see above), the dependent variable DD k total was log-transformed as well 
(further details of the statistical analysis are given in online Supplementary Methods S3). 
Figure 1 shows the effects of group and time for the four main dependent variables, even if the 
main effects and/or interactions of group and time were not statistically significant in the final models 
that are reported in Table 2. In such cases, these effects were added to the final model and the figures 
were derived from these extended models. 
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Results 
Demographic and clinical characteristics and drug use 
The four groups did not significantly differ regarding age, sex distribution, verbal IQ, years of 
education, smoking status, and length of interval between the two study assessments (Table 1). 
Moreover, all three CU groups showed similar BDI (pSidak post-hoc>.97) and ADHD-SR (pSidak post-hoc>.99) 
sum scores, but exhibited distinctively higher values than HC (pBDI=.08 to .006, pADHD-SR=.03 to .007).  
At baseline, all three CU groups did not display significant differences in the self-reported 
cocaine use parameters and hair concentrations. However, the increaser and decreaser groups clearly 
featured a stronger current and cumulative cocaine use than the equal user group although the 
differences were not statistically significant. Furthermore and in accordance with the inclusion criteria, 
the data showed a clear domination of cocaine compared to other illegal drug use. At follow-up, 
increasers had a three- to four-fold higher cocaine concentration in the hair samples compared to the 
baseline value, whereas decreasers’ values dropped by about three quarters, while the equal users’ 
values remained relatively stable. 
 
Impulsivity and decision-making scores 
Barratt Impulsiveness Scale (BIS-11). At baseline, a combined CU group (including increasers, 
decreasers, and equal users) differed significantly from the HC group in the total score (T103=2.98, 
p<.01) and all three subscales FI to FII (T103=2.32 to 2.83, p=.02 to .006) as previously shown in 
Vonmoos et al. (2013b). The most striking finding was the significant group*time interaction (p<.01) 
in the BIS-11 total score with increasers showing a trend for elevated self-reported impulsivity over 
time (p=.12), whereas decreasers displayed significantly reduced self-reported impulsivity within one 
year (p<.05). Equal users’ (p=.86) and HC’s total scores remained comparatively stable (Figure 1A; a 
p-value for HC is not available because this group was dropped from the regression model due to 
collinearity). Table 2 shows that this pattern of significant group*time interactions (increaser vs. 
decreaser) can also be seen in the BIS-11 primary subscales FI (attentional impulsiveness, p<.05) and 
FII (motor impulsiveness, p<.01). Whereas none of the groups revealed significant time effects in 
attentional impulsiveness (pdec=.17, pinc=.08, pequal=.28, pHC=.48), decreasers showed a significant 
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reduction in the self-reported motor impulsiveness (pdec<.01, pinc=.13, pequal=.92, pHC=.18). For the 
BIS-11 subscale FIII (non-planning impulsiveness) no significant group*time interaction (increaser vs 
decreaser) was found (p=.15). 
Additionally, BIS-11 total, attentional, and motor impulsiveness scores correlated strongly with 
ADHD-SR sum scores (all p<.002). Furthermore, BIS-11 total, attentional, and nonplanning scores 
were positively associated with BDI depression (all p<.05). BIS-11 total (p<.05) and nonplanning 
scores (p<.001) positively co-varied with craving scores, and a later age of cocaine onset was linked to 
reduced motor impulsiveness (p<.01). However, this latter effect was no longer significant when 
controls were excluded from the analysis.  
 
Rapid Visual Processing (RVP response bias B’’). For B’’, no baseline differences between CU 
and HC occurred (T103=-1.04, p=.30)(see also Vonmoos et al. 2013b) and in the longitudinal analysis 
there was no significant effect regarding group, time, or their interaction. The only significant finding 
was a weak positive association with duration of cocaine use (p<.05), which was no longer significant 
when excluding the control group from the analysis (Table 2, Figure 1B). 
 
Delay discounting (DD k total). At baseline, CU and HC strongly differed regarding k total 
(T103=-3.40, p<.001), as shown before (Hulka et al. 2014). Longitudinally, k total showed no 
statistically significant group and/or time effects. However, a 100% increase in the cumulative lifetime 
dose of cocaine was associated with roughly a 20% decline in scores of the ability to delay 
gratification – i.e. to forego immediate smaller in favour of delayed larger rewards. Moreover, a 100% 
raise in the FTND score was associated with a 30% decrease in scores for delayed gratification (Table 
2, Figure 1C). 
 
Iowa Gambling Task (IGT total ratio). Baseline scores of the IGT total ratio did not differ 
between CU and HC (T102=.72, p=.47). In the longitudinal analysis, a significant group*time 
interaction was found for the IGT total ratio (p<.05, Table 2, Figure 1D, for a detailed distribution of 
IGT scores for each group at t1 and t2 see online Supplementary Figure S1). Without any 
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statistically significant main effect of group, decreasers’ scores fell during the 1-year-interval (p=.11), 
whereas those of the increasers improved (p=.09). Concretely, this means that decreasers chose 
significantly fewer favourable cards at follow-up. Equal users’ (p=.34) and HC’ (p=.54) total ratio 
scores remained fairly stable. Age (p<.01), an ADHD diagnosis (p<.10), and a positive smoking status 
(p<.01) were related to decreases in IGT performance of roughly 1/3 SD.  
 
Test-retest reliability. In three of the four main variables, HC displayed slightly higher test-
retest reliability scores than the combined CU group (Table 3) but the differences were not significant 
(z<.80, p>.20). Moreover, the BIS-11 total score showed a remarkable strong test-retest reliability, 
whereas the response bias B’’ featured the smallest but nonetheless significant test-retest reliability in 
HC and CU.  
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Discussion 
The present longitudinal study investigated to what extent impaired decision-making and 
elevated impulsivity levels in CU may represent stable and pre-existing addiction endophenotypes vs. 
variable state markers depending on the quantity of cocaine used. The most striking finding was that 
self-reported levels of impulsivity strongly co-varied with changing cocaine use patterns. Accordingly, 
CU who substantially decreased their cocaine intake within one year reported significantly lower 
levels of impulsive behaviour, whereas CU who increased their consumption reported by trend higher 
levels of subjectively perceived impulsivity. By contrast, cognitive impulsivity measures capturing 
impulsive action (response bias B’’) and impulsive choice (delay discounting) did not significantly 
differ with increasing or decreasing cocaine use over the course of one year. Contrary to our 
expectations, CU who decreased their cocaine intake during the one-year-interval chose fewer 
favourable cards in the IGT at the second study assessment, whereas CU who increased their 
consumption showed a slightly improved performance. Nonetheless, there seemed to be a linkage 
between worse decision-making at baseline and a subsequently increased cocaine use pattern 
suggesting that impaired decision-making might indeed be a risk factor for increasing cocaine use.  
The results of the present study are somewhat surprising and call some existing assumptions 
into question. The BIS has been regarded to reflect a relatively stable trait component of subjectively 
experienced impulsivity levels (Stevens et al. 2014). However, our results revealed that CU who 
increased their consumption over the time-course of one year perceived themselves by trend as more 
impulsive, whereas CU who decreased their use rated themselves as less impulsive. Although the BIS 
reliably differentiated CU form HC, and thus might overall reflect a trait component, it is not as stable 
in drug using populations as previously assumed. Therefore, the BIS may be useful to assess how 
subjectively perceived levels of impulsiveness in CU co-vary with drug consumption. Moreover, 
Littlefield et al. (2009) have also provided evidence that impulsivity measures assessed in 
questionnaires change over time. Previously, we have already shown that BIS ratings were elevated in 
dependent CU using substantially higher amounts of cocaine than in recreational CU with a much less 
pronounced cocaine use pattern (Vonmoos et al. 2013b). It is noteworthy that differences (Δt2-t1) in 
self-reported impulsivity between the two testing sessions did not significantly correlate with changes 
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in cognitive impulsivity tasks (CU: r<.30, p>.05; HC: r<-.30, p>.05; total sample: r<-.15, p>.25). This 
finding is in line with prior studies conducted in our lab where trait impulsivity was only weakly 
correlated with behavioural impulsivity task measures (Hulka et al. 2014; Quednow et al. 2007; 
Vonmoos et al. 2013b) and, thus, underlines the multi-facetted concept of the impulsivity construct. 
The reasons why users, who changed their cocaine use pattern, perceived their impulsivity levels to be 
more or less pronounced, remains to be determined in further investigations. One could speculate 
though that the subjective recognition of changes in impulsivity is more sensitive than the behavioural 
measures or that specific facets of impulsivity were not covered by our behavioural tasks. 
Alternatively, CU’ personal thoughts, attitudes, and intentions to change their cocaine use might have 
influenced subjectively reported impulsivity levels. Accordingly, increasers may be more concerned 
with their loss of control over drug intake and/or may also experience more aversive consequences due 
to their increased cocaine use fostering worries. Decreasers on the other hand may have perceived 
themselves as less impulsive because they had a desire to reduce their cocaine use and made a 
conscious effort to control their impulsivity. Correspondingly, research on attentional bias 
modification and substance use has shown that individuals who express a desire to reduce their use 
respond much better to treatment and show less impulsivity (Wiers & Stacy 2006). Moreover, it has 
been shown that increased impulsivity in the BIS is associated with more treatment dropouts and 
shorter treatment duration in CU (Moeller et al. 2001b; Patkar et al. 2004). Therefore, treatment 
approaches should foster awareness in CU that they often act impulsively and without foresight for 
negative consequences, but that these cognitive-behavioural tendencies can be reduced with 
mindfulness-based and other cognitive-behavioural relapse prevention strategies (Dakwar & Levin 
2013). 
It is also noteworthy that self-reported attentional and motor impulsivity were significantly 
associated with more pronounced ADHD symptoms. These results are in line with findings from our 
cross-sectional study (Vonmoos et al. 2013b) as well as with previous studies postulating a substantial 
comorbidity of ADHD with substance use disorders (van Emmerik-van Oortmerssen et al. 2012). 
Unfortunately, we omitted to assess the ADHD-SR questionnaire at the follow-up test session and are 
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therefore not able to directly analyse the co-variation of changes in ADHD symptoms with changes of 
impulsivity measures.  
In the present study, temporal discounting preferences as measured by DD did not vary with 
increased or decreased cocaine use, which is in line with previous propositions that intertemporal 
discounting preferences reflect a stable aspect of personality and can be considered as a trait marker 
(Odum 2011a, b). A growing body of evidence corroborates our finding by showing that individual 
discounting preferences in adolescents and adults are relatively stable over numerous time intervals 
ranging from one week to multiple years (for review see MacKillop 2013). In addition, more 
pronounced delay discounting preferences have been suggested to be predictive of the initiation and 
escalation of drug use (2013; Ersche et al. 2012; Mahoney & Olmstead 2013) as well as poor 
treatment responses in human CU (Washio et al. 2011). Furthermore, a prospective study yielded 
evidence that stronger tendencies to prefer immediate smaller over larger but later available amounts 
are associated with negative outcomes in the financial, academic, and health domains (Mischel et al. 
2011). Altogether, the results of the present study and prior findings suggest that more pronounced 
delay discounting rates may be regarded as a relatively stable addiction endophenotype increasing the 
risk to initiate and maintain drug use (MacKillop 2013; Odum 2011a, b).  
Impulsive action measured by the RVP response bias B’’ was not significantly shifted in our CU 
and did not co-vary with changing drug use patterns. These findings are consistent with the previously 
published results from the cross-sectional part of the ZuCo2St showing that neither recreational nor 
dependent CU differed from controls regarding RVP B’’ and Stop-Signal task performance (Vonmoos 
et al. 2013b). Accordingly, the ecological validity of the RVP response bias B'' regarding the 
measurement of addiction-related impulsive action might be questioned. 
The finding that CU who decreased their consumption chose fewer favourable cards in the IGT 
at the second assessment is somewhat puzzling. In the cross-sectional analysis published previously 
(Hulka et al. 2014), we found that although dependent CU performed slightly worse than HC, the 
effect was not as pronounced as shown in previous studies (Bechara et al. 2002; Kjome et al. 2010; 
Verdejo-Garcia et al. 2007). We speculated that these differences might be explained by the fact that 
we paid our participants with real money according to their performance, which is in contrast to most 
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prior studies reporting substantial differences between CU and HC. In line with our hypothesis are the 
results obtained in another study conducted by Vadhan et al. (2009) where CU were paid in real 
money and also did not perform significantly worse than HC in the IGT, suggesting that motivational 
factors may influence IGT performance in drug users. It is further noteworthy that while cocaine use 
patterns did not significantly differ between the user groups at baseline, decreasers had a higher 
cumulative cocaine usage than equal users and increasers. Therefore, we cannot fully rule out that 
decreasers were overall more impaired in their IGT performance due to their more pronounced 
cocaine use, which may not have been detected in the baseline assessment because of low statistical 
power. 
There are some limitations inherent to this study: First, the sample sizes are relatively small for 
multilevel analyses. However, the data were also analysed with mixed design analyses of covariance 
yielding comparable results (not reported here). Second, in addition to the increased cocaine 
consumption, increasers also drank more alcohol than decreasers and tested positive for recent 
cocaine use more frequently than decreasers. However, the rise in weekly alcohol use was based on an 
increased alcohol intake in only three of 19 cocaine increasers and excluding these subjects did not 
alter the main results. Third, although the group assignment of increasers, decreasers, and equal users 
was based on objective hair toxicology capturing the past six months, for the first six months of the 
time interval we had to rely on self-reported drug measures. Fourth, although our sample consisted of 
CU with relatively little polytoxic drug use, it should be mentioned that at baseline, cocaine increasers 
used low but significantly higher amounts of MDMA (0.04 vs. 0.01 tablet per week) and used 
amphetamine (3.3 vs. 1.3 years) for a longer period than decreasers. Furthermore, at follow-up 
cocaine increasers revealed a slightly higher use of MDMA and methylphenidate compared to 
baseline and had an additional augmentation in weekly alcohol use. Whereas the change in MDMA 
use was less than half a tablet per week, the difference in methylphenidate consumption was explained 
by a single individual. However, exclusion of the single methylphenidate user did not change the main 
results in separate analyses. Thus, although changes in other drugs should be considered as a 
contributing factor to our results, it seems reasonable that compared to the strong increase in cocaine 
use, the effect of changed use of other drugs is likely rather small. Fifth, our CU groups differed from 
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controls regarding ADHD and depressive symptoms, which is in accordance with the current literature 
(Swendsen & Merikangas 2000; Wilson 2007). However, we tried to overcome this constraint by 
introducing these variables in the multilevel regression analyses. 
These one-year longitudinal data indicate for the first time that self-reported impulsivity and 
impulsive choice requiring the integration of risk, reward, and loss contingencies (as measured with 
the IGT) co-vary with changing cocaine use, while a response bias measure and delay discounting 
preferences remain largely unaffected. Accordingly, self-reported impulsivity and gambling decision-
making measures are less suitable for predicting the risk to develop a cocaine use disorder but might 
be used to monitor treatment success. By contrast, the preference for immediate smaller rewards over 
larger delayed rewards seems to be a stable trait marker for cocaine use and, thus, may represent a 
suitable endophenotype for stimulant addiction.  
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Figure legend 
 
Figure 1. Predicted values for baseline (t1) and follow-up (t2) are shown. (A) Development of BIS-11 
total scores within one year. Control group data in raw values (predicted data are not available because 
this group was dropped from the regression model due to collinearity). Group*time interaction 
(increaser*decreaser) p<.01. * p<.05 time effect for cocaine decreasers. (B) Development of RVP 
response bias B’’ within one year. (C) Development of delay discounting parameter k within one year. 
Control group data in raw values (predicted data are not available because this group was dropped 
from the regression model due to collinearity). (D) Development of the IGT total ratio within one year. 
Group*time interaction (increaser*decreaser) p<.05. 
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Table 1. Demographic data and pattern of drug use. 
 Baseline (t1)  1-year follow-up (t2)i 
  Controls (n=48) 
Cocaine  
Increaser 
(n=19) 
Cocaine  
Decreaser 
(n=19) 
Equal cocaine 
users 
(n=19) 
F/χ² df, dferr  
p  Controls (n=48) 
Cocaine  
Increaser 
(n=19) 
Cocaine  
Decreaser 
(n=19) 
Equal cocaine 
users 
(n=19) 
F/χ² df, dferr  
p 
Weeks between t1 and t2 58.2 (10.1) 59.3 (12.1) 61.9 (14.5) 64.8 (16.3) 1.37a 3,101 .26         
Age, y 30.3 (8.9) 31.5 (9.4) 31.4 (8.3) 27.0 (5.6) 1.20a 3,101 .31         
Sex (f/m)  16/32 3/16 5/14 8/11 3.49b 3 .32         
Verbal IQ (MWT-B) 107.6 (10.0) 102.9 (9.7) 103.8 (7.1) 104.5 (9.1) 1.57a 3,101 .20         
Education, y 10.8 (1.8) 10.4 (1.8) 10.0 (1.5) 10.3 (1.6) 0.96a 3,101 .41         
ADHD-SR score (0-22) 7.7 (5.2) 13.5 (9.4)* 14.1 (6.8)* 14.4 (10.2)** 6.31a 3,101 <.001         
ADHD DSM IV (y/n) 0/48 4/15 3/16 4/15 10.72b 3 .01         
BDI score (0-63) 3.5 (3.3) 7.3 (8.0) 8.7 (6.5)** 8.1 (6.2)* 5.83a 3,101 .001         
BDI depression (y/n) 0/48 1/18 1/18 2/17 4.46b 3 .22         
                
Cocaine                
  Times per weekd - 1.6 (1.8) 1.0 (1.3) 0.6 (0.6) 2.51c 2,54 .09  - 1.1 (0.8) 0.3 (0.3)°°° 0.3 (0.2)°°° 15.57c 2,54 <.001 
  Grams per weekd - 2.0 (2.5) 1.7 (2.3) 0.7 (0.6) 2.26c 2,54 .11  - 1.6 (2.5) 0.4 (0.4)° 0.2 (0.3)° 5.39c 2,54 .007 
  Years of use - 7.0 (5.5) 8.2 (5.4) 5.4 (5.0) 1.40c 2,54 .25  - 8.9 (5.4) 9.7 (5.2) 6.3 (5.6) 2.09c 2,54 .13 
  Max. dose (grams/day)k - 4.7 (4.4) 5.9 (6.4) 3 (3.1) 1.78c 2,54 .18  - 3.7 (2.5) 3.1 (2.8) 1.7 (1.5)° 3.53c 2,54 .04 
  Cumulative dose 
( )k
- 1182 (1635) 3698 (8585) 394 (563) 2.21c 2,54 .12  - 91 (119) 49 (89) 18 (25)° 3.35c 2,54 .04 
  Last consumption (days) - 18.5 (25.1) 20.8 (22.2) 42.2 (49.7) 2.72c 2,54 .08  - 7.0 (6.3) 81.4 (145.1) 58.2 (116.6) 2.38c 2,54 .10 
  Cocaine craving (0-70)e - 19.8 (9.5) 17.7 (7.2) 18.4 (7.7) 0.35c 2,54 .71  - 20.5 (10.8) 15.8 (6.2) 15.1 (7.7) 2.32c 2,54 .11 
  Current cocaine   
  dependence (n/y)j - 11/8 13/6 18/1 7.06 2 .03         
  Hair analysis (ng/mg)h                
  Hair analysis (ng/mg)h                
    Cocainetotal - 10.3 (29.2) 14.9 (32.2) 3.2 (9.9) 0.99
c 2,54 .38  - 40.7 (76.1) 4.2 (8.2)° 3.2 (9.4)° 4.38c 2,54 .02 
    Cocaine - 8.2 (23.3) 11.4 (23.9) 2.5 (7.6) 0.98c 2,54 .38  - 31.7 (56.5) 3.1 (5.9)° 2.6 (7.9)° 4.81c 2,54 .01 
    Benzoylecgonine  - 1.9 (5.5) 3.1 (7.6) 0.6 (1.9) 0.99c 2,54 .38  - 8.3 (19.6) 1.0 (2.2) 0.4 (1.2) 2.82c 2,54 .07 
    Cocaethylene - 1.0 (2.8) 0.9 (2.8) 0.3 (0.8) 0.45c 2,54 .64  - 1.2 (2.1) 0.3 (1.0) 0.7 (2.1) 1.02c 2,54 .37 
    Norcocaine - 0.2 (0.5) 0.4 (0.8) 0.1 (0.3) 1.11c 2,54 .34  - 0.6 (1.4) 0.1 (0.1) 0.1 (0.3) 2.81c 2,54 .07 
  Urine toxicology (n/p)g 48/0 14/5 16/3 18/1 3.17b 2 .21  48/0 7/12 18/1 16/3 17.90b 2 <.001 
                
Alcohol                
  Grams per weekd 119.9 (136.8) 169.4 (129.2) 155.3 (146.4) 132.3 (86.4) 0.81a 3,101 .49  104.3 (88.6) 259.7 (244.5)*** 127.4 (141.4)° 146.7 (95.1) 5.74a 3,101 .001 
  Years of use 13.3 (8.8) 13.7 (7.6) 12.0 (7.3) 9.9 (5.0) 1.04a 3,101 .38  14.0 (8.7) 14.8 (7.5) 12.6 (7.9) 11.1 (5.5) 0.89a 3,101 .45 
                 
Nicotine                
  Smoking (y/n) 37/11 14/5 14/5 14/5 0.16b 3 .98  40/8 15/4 13/6 15/4 1.83b 3 .61 
  Cigarettes per day 8.7 (8.7) 12.8 (11.2) 9.5 (8.2) 12.2 (8.3) 1.32a 3,101 .27  8.2 (8.7) 13.4 (12.0) 8.2 (7.8) 12.7 (8.9) 2.23a 3,101 .09 
  Years of use 9.3 (8.3) 10.4 (8.9) 12.7 (10.3) 9.2 (6.3) 0.78a 3,100 .51  10.5 (8.8) 12.5 (8.6) 12.6 (9.9) 9.5 (6.7) 0.66a 3,101 .58 
  FTND score 1.8 (2.2) 3.4 (2.7) 2.8 (2.7) 2.2 (2.1) 2.45a 3,101 .07  1.6 (2.3) 3.9 (3.0)** 2.7 (3.0) 2.6 (2.2) 3.73a 3,101 .01 
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Cannabis                
  Grams per weekd 0.6 (1.6) 3.3 (8.9) 1.2 (2.3) 1.2 (2.6) 1.81a 3,101 .15  0.5 (1.6) 2.1 (4.6) 1.1 (2.7) 0.9 (1.6) 1.74a 3,101 .16 
  Years of use 4.5 (4.9) 9.5 (8.5) 10.1 (9.7)* 7.8 (5.9) 4.26a 3,101 .007  4.6 (5.9) 10.5 (9.8)* 8.6 (9.7) 8.4 (6.2) 3.54a 3,101 .02 
  Cumulative dose (grams) 980 (3985) 3199 (5899) 2606 (6359) 19323 (4309) 1.13a 3,101 .34  53.4 (180) 217.8 (526.5) 84.7 (189.6) 55.0 (94.7) 1.83a 3,101 .15 
  Last consumption (days)f 39.3 (55);n=22 10.0 (10);n=14 25.4 (33);n=12 28.7 (41);n=15 1.46a 3,59 .23  36.5 (78);n=22 9.7 (25);n=13 50.8 (75);n=10 18.7 (33);n=13 1.12a 3,54 .35 
  Urine toxicology (n/p)g 42/6 15/4 14/5 16/3 2.08b 3 .56  42/6 7/12 15/4 15/4 19.19b 3 <.001 
                   
Amphetamine                
  Grams per weekd 0.0 (0.1) 0.1 (0.1)* 0.0 (0.1) 0.0 (0.1) 3.17a 3,101 .03  0.0 (0.0) 0.1 (0.2)** 0.0 (0.1) 0.0 (0.1) 3.94a 3,101 .01 
  Years of use 0.0 (0.0) 3.3 (4.0)*** 1.3 (3.1) 1.4 (3.0) 8.45a 3,101 <.001  0.1 (0.5) 3.2 (4.9)** 2.7 (5.5)* 1.9 (3.5) 5.07a 3,101 .003 
  Cumulative dose (grams) 0.0 (0.1) 56.0 (177.6)* 16.2 (35.9) 2.8 (5.8) 2.58a 3,101 .06  0.0 (0.1) 4.4 (8.9)** 1.4 (3.5) 1.9 (6.0) 3.85a 3,101 .01 
  Last consumption (days)f 121.6 (-);n=1 73.6 (62);n=10 90.9 (81);n=3 61.8 (60);n=7 0.34a 3,17 .79  17.5 (-);n=1 35.7 (32);n=8 99.8 (108);n=4 65.9 (23);n=3 1.18a 3,12 .36 
  Hair analysis (ng/mg)h 0.0 (0.0) 0.1 (0.2)* 0.0 (0.0) 0.0 (0.0) 3.43a 3,101 .02  0.0 (0.0) 0.1 (0.2) 0.1 (0.2) 0.0 (0.0) 2.56a 3,101 .06 
                 
MDMA                
  Tablets per weekd 0.0 (0.0) 0.0 (0.1)** 0.0 (0.0) 0.0 (0.0) 5.11a 3,101 .002  0.0 (0.0) 0.4 (0.9)** 0.0 (0.0)° 0.1 (0.1) 4.49a 3,101 .01 
  Years of use 0.3 (1.0) 3.5 (4.5)** 2.4 (4.6) 2.1 (3.8) 5.35a 3,101 .002  0.2 (1.4) 3.8 (5.5)** 3.2 (5.6)* 2.6 (4.3) 5.26a 3,101 .002 
  Cumulative dose (tablets) 1.3 (4.0) 108.8 (249.7)** 18.7 (46.2) 14.6 (39.9) 4.61a 3,101 .005  0.2 (0.8) 17.0 (49.3)* 2.8 (5.2) 4.3 (7.1) 2.91a 3,101 .04 
  Last consumption (days)f 5.0 (-);n=1 89.9 (65);n=7 40.2 (34);n=4 56.4 (43);n=6 1.32a 3,14 .31  91.2 (30);n=3 41.6 (55);n=6 47.8 (48);n=5 69.7 (36.4);n=8 1.10a 3,18 .38 
  Hair analysis (ng/mg)h 0.0 (0.0) 0.3 (0.7) 0.4 (1.5) 0.2 (0.5) 1.69a 3,101 .17  0.0 (0.0) 0.5 (0.8)*** 0.1 (0.3) 0.2 (0.4) 5.71a 3,101 <.001 
                 
GHB                
  Cumulative dose (pipettes) 0.0 (0.0) 0.5 (0.7) 0.5 (1.7) 4.5 (17.8) 1.71a 3,101 .17  0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 1.2 (5.2) 1.68a 3,101 .18 
                 
Hallucinogens                
  Cumulative dose (times) 0.9 (2.2) 27.9 (72.8)* 9.9 (22.9) 6.3 (14.3) 3.10a 3,101 .03  0.0 (0.0) 1.1 (1.6)*** 0.6 (1.5) 0.4 (0.8) 6.18a 3,101 <.001 
                 
Methlyphenidate                
  Cumulative dose (tablets) 0.0 (0.0) 20.2 (60.4) 0.5 (2.3) 41.3 (144.6) 2.05a 3,101 .11  0.0 (0.1) 67.7 (239.5) 0.3 (0.6) 1.5 (4.6) 2.30a 3,101 .08 
  Hair analysis (ng/mg)h 0.0 (0.0) 0.0 (0.1) 0.0 (0.0) 0.0 (0.0) 1.40a 3,101 .25  0.0 (0.0) 0.1 (0.2)* 0.0 (0.0) 0.0 (0.0) 2.99a 3,101 .03 
 
Means and standard deviations. Significant p values are shown in bold.  
a ANOVA (all groups, with significant Sidak post-hoc test vs. control group: *p<.05; **p<.01; ***p<.001; vs. cocaine increaser: °p<.05). b χ²-test (all groups/cocaine users only) for frequency data. c ANOVA (cocaine 
users only, with significant Sidak post-hoc test vs. cocaine increaser: °p<.05; °°°p<.001). d Average use during the last 6 months. e Craving for cocaine was assessed by the CCQ, f Last consumption is averaged only for 
persons who used the drug in the last 6 months. g Urine toxicology (neg/pos) are based on cut-off value for Cocaine = 150 ng/ml and for Tetrahydrocannabinol 50 ng/ml (Substance Abuse and Mental Health Services 
Administration 2008). The χ²-test for cocaine includes only cocaine users, the χ²-test for cannabis includes all groups.  h Hair samples were voluntary and data are missing for three controls.  
i Parameters at follow-up refer to the 1-year period between t1 and t2. j SCID-I diagnosis according to DSM-IV criteria (APA, 1994). 
 27 
Table 2. Coefficients (standard errors) of final multilevel regression models with standardized dependent variables 
 
RVP  
Response bias B’’a 
BIS-11  
Total scorea 
BIS-11 FI 
Attentional imp.a 
BIS-11 FII  
Motor imp.a 
BIS-11 FIII  
Nonplanning imp.a 
DD  
K total [log]a 
IGT  
Total scorea 
Time        
  t  0.234 (0.15) 0.303+ (0.17) 0.273 (0.18)   0.403+ (0.24) 
        
Group        
  Equal users (vs incb)  0.144 (0.28) 0.175 (0.22) 0.208 (0.29)   -0.232 (0.31) 
  Decreasers (vs incb)  0.294 (0.28) 0.074 (0.22) 0.403 (0.29)   -0.077 (0.31) 
  Controls (vs incb)   0.198 (0.19) 0.135 (0.25)   -0.174 (0.26) 
        
Group x time        
  Equal users (vs incb) x t  -0.206 (0.22) -0.489* (0.24) -0.292 (0.26)   -0.173 (0.34) 
  Dec (vs incb) x t  -0.568** (0.21) -0.532* (0.24) -0.836** (0.25)   -0.786* (0.34) 
  Controls (vs incb) x t   -0.229 (0.20) -0.423* (0.21)   -0.313 (0.28) 
        
Demographics        
  Age [per 10 y]       -0.310** (0.09) 
        
Clinical statuse        
  ADHD-SR score  0.385*** (0.10) 0.669*** (0.06) 0.260** (0.09)    
  ADHD DSM IV [y/n]       -0.516+ (0.27) 
  BDI score  0.130* (0.06)   0.149 (0.07)   
  BDI depression [y/n]   0.595* (0.26)     
  Smoking FTND score      0.310* (0.13) -0.215** (0.08) 
  Smoking [y/n] 0.285+ (0.17)   -0.282+ (0.15) -0.348 (0.18)   
        
Cocaine use relatede        
  Age of onset [per 5 y]  -0.161+ (0.09) -0.075+ (0.04)c -0.147** (0.05)d -0.178+ (0.10)   
  Craving score [per SD|  0.190* (0.07)   0.237*** (0.07) -0.275+ (0.16)  
  Years of use [years] 0.035* (0.02)d       
  Cumulative dose [grams; log]      0.177* (0.08)  
Significance levels: +p<.10; *p<.05; **p<.01; ***p<.001. 
a All dependent variables divided by standard deviation. b Increasers. c No longer significant when excluding controls. d Only trend-level significant when excluding controls. e Values at baseline (t1). 
The table shows all coefficients that are relevant for the final models. Principally, final models included only predictors at p<.10. However, in case of any significant interaction effects (group*time), the table additionally 
displays the single terms (group, time).
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Table 3. One-year test-retest reliability between baseline and one-year follow up in controls and cocaine users 
 
 Controls (n=48) Cocaine users (n=57) 
BIS total score     .81***   .75*** 
RVP respone bias B'' .30* .35** 
DD k total [log]    .52***   .43*** 
IGT total score   .45** .43** 
Pearson’s product-moment correlation. 
Significance levels: *p<.05; **p<.01; ***p<.001. 
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Methods S1 
 
Participant recruitment: Participants were recruited in the greater area of Zurich from January 
2010 until March 2013. Study participants were recruited via advertisements in local newspapers, 
online media, drug prevention and treatment centers, psychiatric hospitals, and by word of mouth. 
Eight-hundred-and-four prospective participants underwent a standardized telephone interview, 
whereof 240 subjects were tested in the cross-sectional study. Six participants were not re-invited to 
participate in the follow-up study (refusal of study participation, psychiatric disorders or first-grade 
family member with schizophrenia). The remaining 234 participants (138 cocaine users, 96 healthy 
psychostimulant-naive controls [HC]) (Hulka et al. 2014; Preller et al. 2014; Vonmoos et al. 2014) 
were contacted and invited for a follow-up test session twelve months after baseline testing. One-
hundred-and-two participants (59 cocaine users, 43 controls) were not available for the follow-up 
study due to different reasons (no response, losing interest, time reasons, death). One-hundred-and-
thirty-two participants (79 CU [57.3% of baseline], 53 HC [55.2%]) participated in the 1-year-follow-
up. Twenty-seven of these subjects (22 cocaine users, 5 controls) had to be excluded from the final 
analyses due to hair analyses revealing illegal drug use not allowed by our exclusion criteria (e.g., 
opioids or excessive MDMA intake) or due to starting use of psychotropic medication (e.g., 
antipsychotics or antidepressants), leaving a final sample of 57 CU and 48 matched HC.  
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Methods S2 
 
Rapid Visual Processing Task (RVP): The RVP is a visual continuous performance task from 
the Cambridge Neuropsychological Test Automated Battery (CANTAB; www.cantab.com) using 
predefined sequences of three digits presented at a rate of 100 per minute to assess sustained attention 
over a period of 4 min. In order to assess impulsive action, we assessed the response bias B’’ 
reflecting the tendency to respond regardless of the presence of a target and can therefore be 
interpreted as a measure for impulsive behavior (Nuechterlein et al. 2008).  
 
Iowa Gambling Task (IGT): The IGT assesses the ability to choose between favorable card 
decks yielding lower gains but also a lower risk for losses eventually resulting in long-term benefit and 
unfavorable card decks resulting in higher gains but also higher losses leading to long-term loss. A 
computerized version of Grasman and Wagenmakers (University of Amsterdam, Netherlands) was 
used (http://purl.oclc.org/NET/rgrasman/jscript/IowaGamblingTask). Participants had to draw 100 
cards from four different card decks, each containing 50 cards. The net score of good and bad cards 
drawn served as the dependent variable. At the end of the task, points were converted by the factor 
.002 and paid out in real money. All participants started out with 4000 points, with the maximum 
number of points that could be gained at 8000, equaling 16 CHF. 
 
Delay Discounting (DD): In the DD, 27 choices between immediately available lower monetary 
rewards and higher rewards available with a temporal delay were presented. The discounting rate, how 
strongly larger but later available rewards are discounted, was calculated with the Formula V=A/(1+ 
kD)(V is the present value of the delayed reward A at delay D, and k is a free parameter that determines 
the discount rate) (Mazur 1987). A computerized version (implemented in Presentation®) of the DD 
paradigm according to Kirby et al. (1999) was used. The steepness of discounting of delayed rewards 
(expressed as k total; the larger the parameter k, the stronger the discounting of larger delayed 
rewards) was used as the dependent variable. 
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Methods S3 
 
Linear	multilevel	models: For any given dependent variable, to assess whether a random 
intercept was appropriate, we fitted a model without predictors and checked whether a) the standard 
deviation of the random intercept was significantly different from zero and b) whether the Intraclass 
Correlation Coefficient (ICC), which is the proportion of between-subjects variance, was significantly 
greater than zero. This was the case for all models. The appropriateness of a random slope was 
assessed for each level-1 predictor of each model separately, using one-tailed Likelihood-Ratio-Tests. 
In one case, a random slope was added. Finally, model fit, in particular linearity of the relation 
between outcome and predictors, was checked by residual vs fitted plots. 
Because the number of parameters in multilevel models should be adjusted to the sample size 
(Tabachnik & Fidell 2006), we reduced the number of predictors using a strategy adopted from 
(Hosmer & Lemeshow 2000): to fit univariate models, predictors at p<.2 were included in a full 
model. Predictors at p>.1 were then eliminated step-by-step, starting with the least statistically 
significant one. It was ensured that when eliminating a predictor, coefficient estimates for the 
remaining predictors did not change by more than about 25%. Final models included only predictors at 
p<.10. 
In predictors relevant only to CU such as level or duration of consumption, collinearity was to 
be expected with the grouping variable, since the HC always have zero-values, while CU have positive 
values. Therefore, all models were repeated in a dataset excluding HC to check for coefficient 
differences in cocaine-related predictors. In a few cases these coefficients were no longer statistically 
significant. 
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Figure S1 
 
 
	
	
	
Figure S1: Distribution of IGT total ratio scores for each group at t1 and t2. 
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